BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research

Provided by: National Institutes of Health (NIH)
Tags: Tyrosine Kinase Inhibitor Tasigna Gastric Cancers CML Nilotinib BODIPY TKI
Short Description:

This technology pertains to bodipy conjugated tyrosine kinase inhibitors that are currently used in the clinic for the treatment of CML or gastric cancers.

Projects based on this Technology

Start New Project